Ruixin Sun

1.6k total citations
36 papers, 1.3k citations indexed

About

Ruixin Sun is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Ruixin Sun has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Ruixin Sun's work include CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (4 papers). Ruixin Sun is often cited by papers focused on CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (4 papers). Ruixin Sun collaborates with scholars based in China and South Korea. Ruixin Sun's co-authors include Bizhi Shi, Zonghai Li, Hua Jiang, Hong Luo, Yansha Sun, Chuanlong Wu, Su Jingwen, Shengmeng Di, Min Zhou and Lian Wang and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Cancer Research.

In The Last Decade

Ruixin Sun

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruixin Sun China 16 800 506 503 246 171 36 1.3k
Sherly Mardiana Australia 12 1.2k 1.5× 444 0.9× 824 1.6× 306 1.2× 256 1.5× 13 1.5k
Shigeki Yagyu Japan 20 656 0.8× 713 1.4× 216 0.4× 178 0.7× 255 1.5× 67 1.4k
Qingwang Han China 13 729 0.9× 537 1.1× 231 0.5× 219 0.9× 311 1.8× 15 1.3k
Xiaojun Qian China 9 1.3k 1.6× 392 0.8× 521 1.0× 353 1.4× 478 2.8× 22 1.5k
Emilio Sanseviero United States 9 670 0.8× 411 0.8× 1.2k 2.3× 114 0.5× 49 0.3× 10 1.6k
Kenneth C. Valkenburg United States 7 526 0.7× 446 0.9× 313 0.6× 215 0.9× 42 0.2× 8 1.1k
Navin K. Chintala United States 13 850 1.1× 365 0.7× 620 1.2× 255 1.0× 162 0.9× 24 1.3k
Metamia Ciampricotti Netherlands 11 1.0k 1.3× 529 1.0× 1.2k 2.3× 135 0.5× 65 0.4× 13 1.9k
V D Fedorov United States 8 1.1k 1.3× 554 1.1× 381 0.8× 374 1.5× 297 1.7× 20 1.4k
Xiaomeng Hu United States 13 348 0.4× 627 1.2× 261 0.5× 113 0.5× 181 1.1× 34 1.2k

Countries citing papers authored by Ruixin Sun

Since Specialization
Citations

This map shows the geographic impact of Ruixin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruixin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruixin Sun more than expected).

Fields of papers citing papers by Ruixin Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruixin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruixin Sun. The network helps show where Ruixin Sun may publish in the future.

Co-authorship network of co-authors of Ruixin Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Ruixin Sun. A scholar is included among the top collaborators of Ruixin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruixin Sun. Ruixin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lu, Renquan, Ying Wu, Yiwen Yao, et al.. (2025). TERC Stimulates Fatty Acid Metabolism to Promote Bladder Cancer Progression. Cancer Research. 85(19). 3689–3705.
4.
Wu, Chuanlong, Zujun Sun, Chuan He, & Ruixin Sun. (2025). pH-dependent Osteoimmunomodulation: Molecular mechanisms and therapeutic targeting in bone disorders. Pharmacological Research. 218. 107838–107838. 2 indexed citations
5.
Chen, Chen, Ying Wu, Junlu Wu, et al.. (2025). Identification of a panel of lncRNAs derived from urinary extracellular vesicles as non-invasive diagnostic biomarkers for bladder cancer. Clinica Chimica Acta. 575. 120376–120376. 1 indexed citations
6.
7.
Sun, Ruixin, Yunzhe Zhang, Xinchao Wang, et al.. (2024). A new exploration of the amplification mechanism of saltatory rolling circle amplification (SRCA) for food safety detection. LWT. 209. 116757–116757. 4 indexed citations
8.
Niu, Wentao, Zhong Chen, Ruixin Sun, et al.. (2024). Realization of Narrow‐Bandwidth Cu‐Ga‐S‐Based Quantum Dots with Controllable Luminescence. Advanced Optical Materials. 12(23). 6 indexed citations
10.
Sun, Ruixin, Yansha Sun, Chuanlong Wu, et al.. (2023). CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer. Molecular Therapy. 31(11). 3193–3209. 46 indexed citations
11.
Sun, Ruixin, Min Zhou, Hong Luo, et al.. (2023). Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer. Biochemical Pharmacology. 212. 115536–115536. 14 indexed citations
12.
Liu, Yifan, Yansha Sun, Peng Wang, et al.. (2023). FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer. Journal of Translational Medicine. 21(1). 255–255. 68 indexed citations
13.
Zhou, Min, Muhua Chen, Bizhi Shi, et al.. (2022). Radiation enhances the efficacy of EGFR-targeted CAR-T cells against triple-negative breast cancer by activating NF-κB/Icam1 signaling. Molecular Therapy. 30(11). 3379–3393. 43 indexed citations
14.
Luo, Hong, Su Jingwen, Ruixin Sun, et al.. (2020). Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion. Clinical Cancer Research. 26(20). 5494–5505. 129 indexed citations
15.
Di, Shengmeng, Min Zhou, Zeyan Pan, et al.. (2019). Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells. Frontiers in Oncology. 9. 241–241. 71 indexed citations
16.
Tang, Chao, Ruixin Sun, Guodao Wen, et al.. (2019). Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively. Cell Death and Disease. 10(5). 335–335. 30 indexed citations
17.
Luo, Hong, Xiuqi Wu, Ruixin Sun, et al.. (2019). Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells. Frontiers in Oncology. 9. 1448–1448. 36 indexed citations
18.
Li, Shu‐Ting, et al.. (2019). Bromodomain-containing protein 2 promotes lipolysis via ERK/HSL signalling pathway in white adipose tissue of mice. General and Comparative Endocrinology. 281. 105–116. 11 indexed citations
19.
Wu, Chuanlong, Xuqiang Liu, Ruixin Sun, et al.. (2018). Targeting Anion Exchange of Osteoclast, a New Strategy for Preventing Wear Particles Induced- Osteolysis. Frontiers in Pharmacology. 9. 1291–1291. 6 indexed citations
20.
Wang, Jingyu, Ruixin Sun, Yu-Xiong Wang, et al.. (2013). Brd2 Inhibits Adipogenesis via the ERK1/2 Signaling Pathway in 3T3-L1 Adipocytes. PLoS ONE. 8(10). e78536–e78536. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026